AstraZeneca expanding pain control centre in Montreal

AstraZeneca Canada Inc is investing $10 million in an expansion of its pain control research centre in Montreal. The $300-million centre opened in 1997 in the Saint-Laurent Technoparc by then Astra Pharma Inc and was the company's first major R&D facility outside of its home base in Sweden (R$, May 28/97). It employs 125 scientists and is one three basic pharmaceutical research centres in Canada. Since its inception it has discovered six promising compounds. The firm says the 1,000 sq-m expansion and new equipment will facilitate the transfer of chemists from a nearby site and provide room for future growth....